267 related articles for article (PubMed ID: 24732629)
1. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.
Kristal AR; Till C; Song X; Tangen CM; Goodman PJ; Neuhauser ML; Schenk JM; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1494-504. PubMed ID: 24732629
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Schwartz GG
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1447-9. PubMed ID: 25085835
[TBL] [Abstract][Full Text] [Related]
3. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Barrington WE; Schenk JM; Etzioni R; Arnold KB; Neuhouser ML; Thompson IM; Lucia MS; Kristal AR
JAMA Oncol; 2015 Jun; 1(3):342-9. PubMed ID: 26181184
[TBL] [Abstract][Full Text] [Related]
4. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Martinez EE; Darke AK; Tangen CM; Goodman PJ; Fowke JH; Klein EA; Abdulkadir SA
Cancer Prev Res (Phila); 2014 Sep; 7(9):950-7. PubMed ID: 24894197
[TBL] [Abstract][Full Text] [Related]
5. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
6. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
Kristal AR; Darke AK; Morris JS; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Lippman SM; Klein EA
J Natl Cancer Inst; 2014 Mar; 106(3):djt456. PubMed ID: 24563519
[TBL] [Abstract][Full Text] [Related]
7. Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Albanes D; Till C; Klein EA; Goodman PJ; Mondul AM; Weinstein SJ; Taylor PR; Parnes HL; Gaziano JM; Song X; Fleshner NE; Brown PH; Meyskens FL; Thompson IM
Cancer Prev Res (Phila); 2014 Sep; 7(9):886-95. PubMed ID: 24961880
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
10. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Lippman SM; Klein EA; Goodman PJ; Lucia MS; Thompson IM; Ford LG; Parnes HL; Minasian LM; Gaziano JM; Hartline JA; Parsons JK; Bearden JD; Crawford ED; Goodman GE; Claudio J; Winquist E; Cook ED; Karp DD; Walther P; Lieber MM; Kristal AR; Darke AK; Arnold KB; Ganz PA; Santella RM; Albanes D; Taylor PR; Probstfield JL; Jagpal TJ; Crowley JJ; Meyskens FL; Baker LH; Coltman CA
JAMA; 2009 Jan; 301(1):39-51. PubMed ID: 19066370
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.
Schenk JM; Till CA; Tangen CM; Goodman PJ; Song X; Torkko KC; Kristal AR; Peters U; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1484-93. PubMed ID: 25085836
[TBL] [Abstract][Full Text] [Related]
12. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Brasky TM; Darke AK; Song X; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Klein EA; Kristal AR
J Natl Cancer Inst; 2013 Aug; 105(15):1132-41. PubMed ID: 23843441
[TBL] [Abstract][Full Text] [Related]
13. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
14. Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):665-9. PubMed ID: 26809275
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
16. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
[TBL] [Abstract][Full Text] [Related]
17. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
19. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.
Gaziano JM; Glynn RJ; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Sesso HD; Buring JE
JAMA; 2009 Jan; 301(1):52-62. PubMed ID: 19066368
[TBL] [Abstract][Full Text] [Related]
20. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
